Skip to Main Content

3,098

Views

0

CrossRef citations to date

0

Altmetric

Original Research

Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis

Jeffrey R. Curtisa Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, USAView further author information

,

Vibeke Strandb Division of Immunology/Rheumatology, Stanford University, Palo Alto, CA, USAView further author information

,

Steven Golombekc Allergy, Asthma & Arthritis Associates, St. Clare’s Health, Denville, NJ, USAView further author information

,

Lixia Zhangd Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Angus Wongd Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Mark C. Zielinskid Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Viatcheslav R. Akmaevd Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Alif Salehd Scipher Medicine Corporation, Waltham, MA, USAView further author information

,

Sam Asgariand Scipher Medicine Corporation, Waltham, MA, USAView further author information

&

Johanna B. Withersd Scipher Medicine Corporation, Waltham, MA, USACorrespondence[email protected]

https://orcid.org/0000-0003-1289-4454 View further author information